tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. we are the only gmp certified medical cannabis producer currently supplying products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in australia, canada, the european union and the americas.
Company profile
Ticker
TLRY
Exchange
Website
CEO
Brendan Kennedy
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Tilray, Inc.
SEC CIK
Corporate docs
Subsidiaries
Natura Naturals Inc. • Tilray, Inc. • Manitoba Harvest USA LLC • Tilray Canada Ltd. • Dorada Ventures Ltd. • FHF Holdings Ltd. • High Park Farms Ltd. • Tilray Deutschland GmbH • Pardal Holdings, Lda. • Tilray Portugal Unipessoal, Lda. ...
TLRY stock data
Latest filings (excl ownership)
8-K
Other Events
16 Feb 24
424B7
Prospectus with selling stockholder info
16 Feb 24
8-K
Unregistered Sales of Equity Securities
6 Feb 24
8-K
Entry into a Material Definitive Agreement
10 Jan 24
424B7
Prospectus with selling stockholder info
10 Jan 24
10-Q
2023 Q2
Quarterly report
9 Jan 24
8-K
Tilray Brands Delivers Record Q2 Fiscal 2024 Net Revenue
9 Jan 24
8-K
Unregistered Sales of Equity Securities
21 Dec 23
8-K
Submission of Matters to a Vote of Security Holders
22 Nov 23
8-K
Other Events
13 Oct 23
Transcripts
TLRY
Earnings call transcript
2024 Q2
9 Jan 24
TLRY
Earnings call transcript
2024 Q1
4 Oct 23
TLRY
Earnings call transcript
2023 Q4
26 Jul 23
TLRY
Earnings call transcript
2023 Q4
26 Jul 23
TLRY
Earnings call transcript
2023 Q3
10 Apr 23
TLRY
Earnings call transcript
2023 Q2
9 Jan 23
TLRY
Earnings call transcript
2023 Q1
7 Oct 22
TLRY
Earnings call transcript
2022 Q4
28 Jul 22
TLRY
Earnings call transcript
2022 Q3
6 Apr 22
TLRY
Earnings call transcript
2022 Q2
10 Jan 22
Latest ownership filings
Financial summary
Quarter (USD) | Nov 23 | Aug 23 | May 23 | Feb 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | May 23 | May 22 | May 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 144.95 mm | 144.95 mm | 144.95 mm | 144.95 mm | 144.95 mm | 144.95 mm |
Cash burn (monthly) | 11.39 mm | 3.77 mm | 16.52 mm | 118.05 mm | 10.14 mm | 1.77 mm |
Cash used (since last report) | 45.44 mm | 15.04 mm | 65.89 mm | 470.80 mm | 40.43 mm | 7.07 mm |
Cash remaining | 99.51 mm | 129.90 mm | 79.06 mm | -325.85 mm | 104.52 mm | 137.88 mm |
Runway (months of cash) | 8.7 | 34.4 | 4.8 | -2.8 | 10.3 | 77.7 |
Institutional ownership, Q3 2023
13.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 351 |
Opened positions | 350 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 214.30 bn |
Total shares | 96.90 mm |
Total puts | 7.89 mm |
Total calls | 16.32 mm |
Total put/call ratio | 0.5 |
Largest owners | Shares | Value |
---|---|---|
Hudson Bay Capital Management | 16.18 mm | $38.67 bn |
Millennium Management | 11.94 mm | $28.54 bn |
CVI Investments | 7.01 mm | $57.93 mm |
MS Morgan Stanley | 4.33 mm | $10.36 bn |
Susquehanna International | 3.88 mm | $9.26 bn |
Vanguard | 3.18 mm | $7.59 bn |
BLK Blackrock | 2.66 mm | $6.35 bn |
BNP Paribas Arbitrage | 2.54 mm | $6.06 bn |
BMO Bank of Montreal | 2.41 mm | $5.65 bn |
Mirae Asset Global Investments | 2.40 mm | $5.72 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
19 Jan 24 | Renah Persofsky | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 129,534 | 0.00 | 0 |
17 Jan 24 | Faltischek Denise M | Common Stock | Buy | Acquire P | No | No | 2.05 | 10,000 | 20.50 k | 293,269 |
16 Jan 24 | Gendel Mitchell | Common Stock | Buy | Acquire P | No | No | 1.98 | 7,200 | 14.26 k | 195,796 |
12 Jan 24 | Carl A Merton | Common Stock | Buy | Acquire P | Yes | No | 1.87 | 20,000 | 37.40 k | 20,000 |
12 Jan 24 | Simon Irwin D | Common Stock | Buy | Acquire P | No | No | 1.88 | 53,700 | 100.96 k | 2,033,058 |
News
Tim Seymour Sees High Times Ahead For Cannabis Stocks
28 Mar 24
Cannabis Stock Gainers And Losers From March 27, 2024
27 Mar 24
'GOP Senators Tell DEA To Reject Marijuana Rescheduling, Arguing It Would Violate International Treaties' - Marijuana Moment
27 Mar 24
Cannabis Stock Movers For March 26, 2024
26 Mar 24
Dada Nexus Posts Downbeat Results, Joins GDS Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
26 Mar 24
Press releases
SweetWater Brewing Launches Hammer Red Amber Ale to Support Georgia Aquarium
28 Mar 24
Actinium Pharmaceuticals (ATNM) Spearheading the Future of Oncology with Iomab-ACT's Innovative Clinical Trial
27 Mar 24
Tilray Medical Receives Approval for First Medical Cannabis Extract in Portugal
14 Mar 24
Tilray Wellness Introduces New Superfood Products Powered by Hemp at Expo West
13 Mar 24
Tilray Introduces New Naturally Flavoured CBG Infused Cannabis Beverages
13 Mar 24